Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Journal for Immunotherapy of Cancer|January 7, 2022
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b studyAkie Kimura Yoshikawa, Kensei Yamaguchi, Kei Muro, et al.
Surgery|November 23, 2017
Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorizationHideki Ueno, Shigeki Sekine, Taihei Oshiro, et al.
Future Oncology (London, England)|December 17, 2025
Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancerYuri Yoshinami, Shotaro Yamaguchi, Hirokazu Shoji, et al.
Oncotarget|December 10, 2017
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapyHirokazu Shoji, Kohei Tada, Shigehisa Kitano, et al.
The Journal of Dermatology|November 8, 2018
Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruptionKatsuko Kikuchi, Keiko Nozawa, Naoya Yamazaki, et al.
JNCI Cancer Spectrum|April 11, 2026
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancerErika Machida, Yasuyuki Takamizawa, Daisuke Takayanagi, et al.
Oncology|October 30, 2017
Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell CarcinomaKazuki Sudo, Ken Kato, Hiroki Kuwabara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 19, 2019
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancerDaisuke Takahari, Keisho Chin, Naoki Ishizuka, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 7, 2025
Impact of multidisciplinary team intervention on long-term survival in distant metastatic colorectal cancer: Single-centre propensity score analysesTetsuo Sugishita, Yukihide Kanemitsu, Jun Imaizumi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2024
Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 studyAtsuo Takashima, Pilar García-Alfonso, Raimundo Manneh, et al.
Pageof 19